Selected research
Market Outlook & Growth Opportunities
Global Medical-assisted Diagnostic Software Market Outlook and Growth Opportunities 2026
Market perspective
The global Medical-assisted Diagnostic Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Medical-assisted Diagnostic Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical-assisted Diagnostic Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical-assisted Diagnostic Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Medical-assisted Diagnostic Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Medical-assisted Diagnostic Software market include MEDO, Nanox Imaging, Predible Health, Perimeter Medical Imaging AI, Ultromics, Therapixel, Quantib, Avicenna.AI and Agfa HealthCare, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Medical-assisted Diagnostic Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical-assisted Diagnostic Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical-assisted Diagnostic Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical-assisted Diagnostic Software market.
Medical-assisted Diagnostic Software Segment by Company
MEDO
Nanox Imaging
Predible Health
Perimeter Medical Imaging AI
Ultromics
Therapixel
Quantib
Avicenna.AI
Agfa HealthCare
EchoNous
Lepu (Beijing) Medical Device Co., Ltd
Beijing Eagle Pupil Technology Development Co., Ltd
Nanjing Silicon-based Intelligent Technology Co., Ltd
Shanghai YITU Network Technology Co., Ltd
Kangda Intercontinental Medical Devices Co., Ltd
Sanowei Technology (Beijing) Co., Ltd
Shenzhen Beistar Medical Co., Ltd
Mingfeng Medical Systems Co., Ltd
Neusoft Medical Systems Co., Ltd
Medical-assisted Diagnostic Software Segment by Type
Ophthalmology
Orthopaedics
Thoracic Surgery
Medical-assisted Diagnostic Software Segment by Application
Hospital
Clinic
Medical-assisted Diagnostic Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Medical-assisted Diagnostic Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Medical-assisted Diagnostic Software key companies, revenue, market share, and recent developments.
3. To split the Medical-assisted Diagnostic Software breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Medical-assisted Diagnostic Software market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Medical-assisted Diagnostic Software significant trends, drivers, influence factors in global and regions.
6. To analyze Medical-assisted Diagnostic Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical-assisted Diagnostic Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical-assisted Diagnostic Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical-assisted Diagnostic Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical-assisted Diagnostic Software industry.
Chapter 3: Detailed analysis of Medical-assisted Diagnostic Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Medical-assisted Diagnostic Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Medical-assisted Diagnostic Software in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Ophthalmology
- Orthopaedics
- Thoracic Surgery
Applications
- Hospital
- Clinic
Companies covered
- MEDO
- Nanox Imaging
- Predible Health
- Perimeter Medical Imaging AI
- Ultromics
- Therapixel
- Quantib
- Avicenna.AI
- Agfa HealthCare
- EchoNous
- Lepu (Beijing) Medical Device Co., Ltd
- Beijing Eagle Pupil Technology Development Co., Ltd
- Nanjing Silicon-based Intelligent Technology Co., Ltd
- Shanghai YITU Network Technology Co., Ltd
- Kangda Intercontinental Medical Devices Co., Ltd
- Sanowei Technology (Beijing) Co., Ltd
- Shenzhen Beistar Medical Co., Ltd
- Mingfeng Medical Systems Co., Ltd
- Neusoft Medical Systems Co., Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical-assisted Diagnostic Software Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical-assisted Diagnostic Software Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical-assisted Diagnostic Software Market Dynamics
- 2.1 Medical-assisted Diagnostic Software Industry Trends
- 2.2 Medical-assisted Diagnostic Software Industry Drivers
- 2.3 Medical-assisted Diagnostic Software Industry Opportunities and Challenges
- 2.4 Medical-assisted Diagnostic Software Industry Restraints
3 Medical-assisted Diagnostic Software Market by Company
- 3.1 Global Medical-assisted Diagnostic Software Company Revenue Ranking in 2025
- 3.2 Global Medical-assisted Diagnostic Software Revenue by Company (2021-2026)
- 3.3 Global Medical-assisted Diagnostic Software Company Ranking (2024-2026)
- 3.4 Global Medical-assisted Diagnostic Software Company Manufacturing Base and Headquarters
- 3.5 Global Medical-assisted Diagnostic Software Company Product Type and Application
- 3.6 Global Medical-assisted Diagnostic Software Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Medical-assisted Diagnostic Software Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Medical-assisted Diagnostic Software Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Medical-assisted Diagnostic Software Market by Type
- 4.1 Medical-assisted Diagnostic Software Type Introduction
- 4.1.1 Ophthalmology
- 4.1.2 Orthopaedics
- 4.1.3 Thoracic Surgery
- 4.2 Global Medical-assisted Diagnostic Software Sales Value by Type
- 4.2.1 Global Medical-assisted Diagnostic Software Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical-assisted Diagnostic Software Sales Value by Type (2021-2032)
- 4.2.3 Global Medical-assisted Diagnostic Software Sales Value Share by Type (2021-2032)
5 Medical-assisted Diagnostic Software Market by Application
- 5.1 Medical-assisted Diagnostic Software Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Medical-assisted Diagnostic Software Sales Value by Application
- 5.2.1 Global Medical-assisted Diagnostic Software Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical-assisted Diagnostic Software Sales Value by Application (2021-2032)
- 5.2.3 Global Medical-assisted Diagnostic Software Sales Value Share by Application (2021-2032)
6 Medical-assisted Diagnostic Software Regional Value Analysis
- 6.1 Global Medical-assisted Diagnostic Software Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical-assisted Diagnostic Software Sales Value by Region (2021-2032)
- 6.2.1 Global Medical-assisted Diagnostic Software Sales Value by Region: 2021-2026
- 6.2.2 Global Medical-assisted Diagnostic Software Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical-assisted Diagnostic Software Sales Value (2021-2032)
- 6.3.2 North America Medical-assisted Diagnostic Software Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Medical-assisted Diagnostic Software Sales Value (2021-2032)
- 6.4.2 Europe Medical-assisted Diagnostic Software Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Medical-assisted Diagnostic Software Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Medical-assisted Diagnostic Software Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Medical-assisted Diagnostic Software Sales Value (2021-2032)
- 6.6.2 South America Medical-assisted Diagnostic Software Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Medical-assisted Diagnostic Software Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Medical-assisted Diagnostic Software Sales Value Share by Country, 2025 VS 2032
7 Medical-assisted Diagnostic Software Country-level Value Analysis
- 7.1 Global Medical-assisted Diagnostic Software Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Medical-assisted Diagnostic Software Sales Value by Country (2021-2032)
- 7.2.1 Global Medical-assisted Diagnostic Software Sales Value by Country (2021-2026)
- 7.2.2 Global Medical-assisted Diagnostic Software Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.7.2 France Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.14.2 China Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.17.2 India Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Medical-assisted Diagnostic Software Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Medical-assisted Diagnostic Software Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Medical-assisted Diagnostic Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 MEDO
- 8.1.1 MEDO Company Information
- 8.1.2 MEDO Business Overview
- 8.1.3 MEDO Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.1.4 MEDO Medical-assisted Diagnostic Software Product Portfolio
- 8.1.5 MEDO Recent Developments
- 8.2 Nanox Imaging
- 8.2.1 Nanox Imaging Company Information
- 8.2.2 Nanox Imaging Business Overview
- 8.2.3 Nanox Imaging Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.2.4 Nanox Imaging Medical-assisted Diagnostic Software Product Portfolio
- 8.2.5 Nanox Imaging Recent Developments
- 8.3 Predible Health
- 8.3.1 Predible Health Company Information
- 8.3.2 Predible Health Business Overview
- 8.3.3 Predible Health Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.3.4 Predible Health Medical-assisted Diagnostic Software Product Portfolio
- 8.3.5 Predible Health Recent Developments
- 8.4 Perimeter Medical Imaging AI
- 8.4.1 Perimeter Medical Imaging AI Company Information
- 8.4.2 Perimeter Medical Imaging AI Business Overview
- 8.4.3 Perimeter Medical Imaging AI Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.4.4 Perimeter Medical Imaging AI Medical-assisted Diagnostic Software Product Portfolio
- 8.4.5 Perimeter Medical Imaging AI Recent Developments
- 8.5 Ultromics
- 8.5.1 Ultromics Company Information
- 8.5.2 Ultromics Business Overview
- 8.5.3 Ultromics Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.5.4 Ultromics Medical-assisted Diagnostic Software Product Portfolio
- 8.5.5 Ultromics Recent Developments
- 8.6 Therapixel
- 8.6.1 Therapixel Company Information
- 8.6.2 Therapixel Business Overview
- 8.6.3 Therapixel Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.6.4 Therapixel Medical-assisted Diagnostic Software Product Portfolio
- 8.6.5 Therapixel Recent Developments
- 8.7 Quantib
- 8.7.1 Quantib Company Information
- 8.7.2 Quantib Business Overview
- 8.7.3 Quantib Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.7.4 Quantib Medical-assisted Diagnostic Software Product Portfolio
- 8.7.5 Quantib Recent Developments
- 8.8 Avicenna.AI
- 8.8.1 Avicenna.AI Company Information
- 8.8.2 Avicenna.AI Business Overview
- 8.8.3 Avicenna.AI Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.8.4 Avicenna.AI Medical-assisted Diagnostic Software Product Portfolio
- 8.8.5 Avicenna.AI Recent Developments
- 8.9 Agfa HealthCare
- 8.9.1 Agfa HealthCare Company Information
- 8.9.2 Agfa HealthCare Business Overview
- 8.9.3 Agfa HealthCare Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.9.4 Agfa HealthCare Medical-assisted Diagnostic Software Product Portfolio
- 8.9.5 Agfa HealthCare Recent Developments
- 8.10 EchoNous
- 8.10.1 EchoNous Company Information
- 8.10.2 EchoNous Business Overview
- 8.10.3 EchoNous Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.10.4 EchoNous Medical-assisted Diagnostic Software Product Portfolio
- 8.10.5 EchoNous Recent Developments
- 8.11 Lepu (Beijing) Medical Device Co., Ltd
- 8.11.1 Lepu (Beijing) Medical Device Co., Ltd Company Information
- 8.11.2 Lepu (Beijing) Medical Device Co., Ltd Business Overview
- 8.11.3 Lepu (Beijing) Medical Device Co., Ltd Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.11.4 Lepu (Beijing) Medical Device Co., Ltd Medical-assisted Diagnostic Software Product Portfolio
- 8.11.5 Lepu (Beijing) Medical Device Co., Ltd Recent Developments
- 8.12 Beijing Eagle Pupil Technology Development Co., Ltd
- 8.12.1 Beijing Eagle Pupil Technology Development Co., Ltd Company Information
- 8.12.2 Beijing Eagle Pupil Technology Development Co., Ltd Business Overview
- 8.12.3 Beijing Eagle Pupil Technology Development Co., Ltd Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.12.4 Beijing Eagle Pupil Technology Development Co., Ltd Medical-assisted Diagnostic Software Product Portfolio
- 8.12.5 Beijing Eagle Pupil Technology Development Co., Ltd Recent Developments
- 8.13 Nanjing Silicon-based Intelligent Technology Co., Ltd
- 8.13.1 Nanjing Silicon-based Intelligent Technology Co., Ltd Company Information
- 8.13.2 Nanjing Silicon-based Intelligent Technology Co., Ltd Business Overview
- 8.13.3 Nanjing Silicon-based Intelligent Technology Co., Ltd Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.13.4 Nanjing Silicon-based Intelligent Technology Co., Ltd Medical-assisted Diagnostic Software Product Portfolio
- 8.13.5 Nanjing Silicon-based Intelligent Technology Co., Ltd Recent Developments
- 8.14 Shanghai YITU Network Technology Co., Ltd
- 8.14.1 Shanghai YITU Network Technology Co., Ltd Company Information
- 8.14.2 Shanghai YITU Network Technology Co., Ltd Business Overview
- 8.14.3 Shanghai YITU Network Technology Co., Ltd Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.14.4 Shanghai YITU Network Technology Co., Ltd Medical-assisted Diagnostic Software Product Portfolio
- 8.14.5 Shanghai YITU Network Technology Co., Ltd Recent Developments
- 8.15 Kangda Intercontinental Medical Devices Co., Ltd
- 8.15.1 Kangda Intercontinental Medical Devices Co., Ltd Company Information
- 8.15.2 Kangda Intercontinental Medical Devices Co., Ltd Business Overview
- 8.15.3 Kangda Intercontinental Medical Devices Co., Ltd Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.15.4 Kangda Intercontinental Medical Devices Co., Ltd Medical-assisted Diagnostic Software Product Portfolio
- 8.15.5 Kangda Intercontinental Medical Devices Co., Ltd Recent Developments
- 8.16 Sanowei Technology (Beijing) Co., Ltd
- 8.16.1 Sanowei Technology (Beijing) Co., Ltd Company Information
- 8.16.2 Sanowei Technology (Beijing) Co., Ltd Business Overview
- 8.16.3 Sanowei Technology (Beijing) Co., Ltd Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.16.4 Sanowei Technology (Beijing) Co., Ltd Medical-assisted Diagnostic Software Product Portfolio
- 8.16.5 Sanowei Technology (Beijing) Co., Ltd Recent Developments
- 8.17 Shenzhen Beistar Medical Co., Ltd
- 8.17.1 Shenzhen Beistar Medical Co., Ltd Company Information
- 8.17.2 Shenzhen Beistar Medical Co., Ltd Business Overview
- 8.17.3 Shenzhen Beistar Medical Co., Ltd Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.17.4 Shenzhen Beistar Medical Co., Ltd Medical-assisted Diagnostic Software Product Portfolio
- 8.17.5 Shenzhen Beistar Medical Co., Ltd Recent Developments
- 8.18 Mingfeng Medical Systems Co., Ltd
- 8.18.1 Mingfeng Medical Systems Co., Ltd Company Information
- 8.18.2 Mingfeng Medical Systems Co., Ltd Business Overview
- 8.18.3 Mingfeng Medical Systems Co., Ltd Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.18.4 Mingfeng Medical Systems Co., Ltd Medical-assisted Diagnostic Software Product Portfolio
- 8.18.5 Mingfeng Medical Systems Co., Ltd Recent Developments
- 8.19 Neusoft Medical Systems Co., Ltd
- 8.19.1 Neusoft Medical Systems Co., Ltd Company Information
- 8.19.2 Neusoft Medical Systems Co., Ltd Business Overview
- 8.19.3 Neusoft Medical Systems Co., Ltd Medical-assisted Diagnostic Software Revenue and Gross Margin (2021-2026)
- 8.19.4 Neusoft Medical Systems Co., Ltd Medical-assisted Diagnostic Software Product Portfolio
- 8.19.5 Neusoft Medical Systems Co., Ltd Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst